Please login to the form below

Not currently logged in
Email:
Password:

Further Tylenol recall for J&J

Johnson & Johnson's McNeil Consumer Healthcare division has announced the voluntary recall of one product lot of Tylenol extra strength caplets in the US following reports of a 'mouldy odour'

Johnson & Johnson's McNeil Consumer Healthcare division has announced the voluntary recall of one product lot of Tylenol extra strength caplets in the US following reports of a 'mouldy odour'.

Around 60,000 bottles are affected, with the unusual smell linked to trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA), a by-product of a chemical preservative sometimes applied to wood often used in the construction of pallets on which materials are transported.

Earlier this month, J&J's Ortho-McNeil-Janssen subsidiary voluntarily recalled one unit each of schizophrenia drugs Risperdal and risperidone for a similar reason.

J&J said: "This voluntary action is being taken as a precaution and the risk of serious adverse medical events is remote. TBA can generate an offensive odour and has been associated with temporary and non-serious gastrointestinal symptoms."

It is recommend that consumers who have purchased the product from the lot number (ABA619 ) stop using the drug and contact McNeil Consumer Healthcare for further information.

The latest announcement follows several Tylenol recalls by McNeil Consumer Healthcare since May 2010.

29th June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Article
How will COVID-19 affect uptake of vaccinations against other diseases?...
Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal
Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma....
Podcast
Living With Chronic Illness (Series one)...

Infographics